During the past decade, Hospital de Braga conducted 71 clinical trials. In the 10-year time frame, 71 clinical trials started and 29 clinical trials were completed, i.e. on average, 40.8% percent of trials that started reached the finish line to date. In the past 5 years, 32 clinical trials started and 25 clinical trials were completed. i.e. 78.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital de Braga" #1 sponsor was "Celgene" with 7 trials, followed by "Hoffmann-La Roche" with 7 trials sponsored, "Janssen Research & Development, LLC" with 6 trials sponsored, "Takeda" with 5 trials sponsored and "Biogen" with 5 trials sponsored. Other sponsors include 42 different institutions and companies that sponsored additional 36 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de Braga" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Clinical Academic Center (2CA-Braga)" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Hospital de Braga" are "Ulcerative Colitis" (8 trials), "Crohn's Disease" (5 trials), "Multiple Sclerosis" (5 trials), "Alzheimer's Disease" (3 trials) and "Depressive Disorder, Major" (3 trials). Many other conditions were trialed in "Hospital de Braga" in a lesser frequency.

Most popular intervention types in "Hospital de Braga" are "Drug" (67 trials), "Other" (7 trials), "Biological" (6 trials), "Device" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (33 trials), "Docetaxel" (3 trials), "GED-0301" (3 trials), "Paclitaxel" (3 trials) and "Aticaprant" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital de Braga" are 74 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are 35 active trials in "Hospital de Braga". 1 are not yet recruiting, 19 are recruiting, 14 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 31 completed trials in Hospital de Braga, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital de Braga, 2 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 53 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 6 trials that are defined as “Not Applicable".